These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16342902)

  • 1. Pelvic irradiation-induced eosinophilia is correlated to prognosis of cervical cancer patients and transient elevation of serum interleukin 5 level.
    Yamazaki H; Inoue T; Tanaka E; Isohashi F; Koizumi M; Shuo X; Nakamura H; Inoue T
    Radiat Med; 2005 Aug; 23(5):317-21. PubMed ID: 16342902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on serum protein fractions of patients with uterine cervical cancer undergoing radiotherapy: relationship between changes in serum protein fractions and prognosis].
    Onizuka K; Migita S; Yamada H; Uwada O; Umemura Y; Kuroki M; Tateyama H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Sep; 54(10):1007-17. PubMed ID: 7971179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies.
    Kasibhatla M; Clough RW; Montana GS; Oleson JR; Light K; Steffey BA; Jones EL
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):398-403. PubMed ID: 16542793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract].
    An JS; Wu LY; Li N; Li B; Yu GZ; Liu LY
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):320-4. PubMed ID: 17673044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration.
    Kazumoto T; Kato S; Tabushi K; Kutsutani-Nakamura Y; Mizuno H; Takahashi M; Shiromizu K; Saito Y
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1157-66. PubMed ID: 17459604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of radiotherapy on serum level of interleukin 6 in patients with cervical carcinoma.
    Tang JT; Yamazaki H; Nishimoto N; Inoue T; Nose T; Koizumi M; Tanaka E; Ogata A; Yoshizaki K; Inoue T
    Anticancer Res; 1996; 16(4A):2005-8. PubMed ID: 8712734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
    Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
    BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-guided interstitial brachytherapy in the treatment of advanced vaginal recurrences from cervical and endometrial carcinoma.
    Weitmann HD; Knocke TH; Waldhäusl C; Pötter R
    Strahlenther Onkol; 2006 Feb; 182(2):86-95. PubMed ID: 16447015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical radiotherapy with high-dose-rate brachytherapy for uterine cervix cancer long-term results.
    Khor TH; Tuan JK; Hee SW; Tham IW
    Australas Radiol; 2007 Dec; 51(6):570-7. PubMed ID: 17958695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification for failure in patients with advanced cervical cancer after concurrent chemoradiotherapy: another way to optimise treatment results.
    Liang JA; Chen SW; Chang WC; Hung YC; Yeh LS; Yang SN; Lin FJ
    Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):683-90. PubMed ID: 18676129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
    Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
    Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix.
    Kaneyasu Y; Nagai N; Nagata Y; Hashimoto Y; Yuki S; Murakami Y; Kenjo M; Kakizawa H; Toyota N; Fujiwara H; Kudo Y; Ito K
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):369-77. PubMed ID: 19735865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].
    Ma SK; Wu LY; Sun YC; Li B; Zhang HT
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):13-7. PubMed ID: 18366925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer.
    Novetsky AP; Einstein MH; Goldberg GL; Hailpern SM; Landau E; Fields AL; Mutyala S; Kalnicki S; Garg M
    Gynecol Oncol; 2007 Jun; 105(3):635-40. PubMed ID: 17331568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal complications of pelvic irradiation for gynecologic cancer.
    Smith AN; Douglas M; McLean N; Ruckley CV; Bruce J
    Surg Gynecol Obstet; 1968 Oct; 127(4):721-8. PubMed ID: 5675187
    [No Abstract]   [Full Text] [Related]  

  • 18. AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial.
    Dobrowsky W; Huigol NG; Jayatilake RS; Kizilbash NI; Okkan S; Kagiya VT; Tatsuzaki H
    Radiother Oncol; 2007 Jan; 82(1):24-9. PubMed ID: 17161478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrence of gynecologic malignancies after combined and primary radiotherapy. Incidence and lapse of time until the diagnosis is made].
    Csaicsich P; Tatra G; Michalica W
    Strahlenther Onkol; 1986 Jul; 162(7):409-13. PubMed ID: 3738739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.